Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
ATRA helps maintain hemostasis
July 4th, 2002
by Michael Greer, senior medical writer - In addition to its anticancer effects, all-trans-retinoic acid (ATRA) can help breast cancer patients maintain hemostasis before surgery, researchers in Italy report. Dr. Anna Falanga and colleagues at Riuniti Hospital in Bergamo, the University of Genoa and the National Cancer Institute in Genoa, and Roche S.p.A. in Monza performed a study to "evaluate whether all-trans-retinoic acid (ATRA) is able to modulate the hemostatic system in [breast cancer] patients with solid tumors". ATRA administration reduced the elevated levels of coagulation activity seen during tamoxifen treatment, Falanga and...
Source: Women's Health Weekly (2002-07-04)
|
